Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bexion Pharmaceuticals logo — Bexion Pharmaceuticals is a mid-stage clinical company devel...

Bexion Pharmaceuticals

Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS.

Founded 2006 United States Covington, United States 27 employees Unknown Total: $18.00M Biopharma, Biotechnology +2

General Information

Company Name Bexion Pharmaceuticals
Founded Year 2006
Location United States Covington, United States +2
Founders / Decision Makers
Team member
Employees 27
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Unknown
Social

Get notified when Bexion Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bexion Pharmaceuticals

Bexion Pharmaceuticals, founded in 2006, is a United States-based company operating at the forefront of the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. The company has carved out a niche in developing transformative treatments within the oncology and central nervous system (CNS) sectors.

The core asset propelling Bexion Pharmaceuticals forward is BXQ-350, a groundbreaking S1P modulator that positions the company to make significant strides in oncological therapies. As a mid-stage clinical company, Bexion is leveraging the deep industry experience of its biotech leadership team to expedite its promising pipeline.

The firm attracted a $16.60M Series B investment on 30 April 2019, underscoring investor confidence in its potential to become a leader in the biotech and pharmaceutical landscape.

Taxonomy: Oncology, CNS (Central Nervous System), S1P Modulator, BXQ-350, Tumor Targeting, Phosphatidylserine Patches, Acid Sphingomyelinase Activation, Ceramide Generation, Caspase Elevation, Biopharmaceutical, Clinical Development, Novel Mechanism of Action, Tumor Neovasculature, Apoptosis Induction

Services & Products

Development of cancer therapies
Clinical-stage drug development
Phase 1b/2a clinical trials
Biologic therapy research

Target Customers

Cancer patients Oncologists Clinical researchers Biopharmaceutical investors

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Nov 2024
Early VC •••••• - 01 Apr 2019
Seed •••••• 1 •••• •••• 01 Nov 2008
Spinout •••••• 1
Investor
01 Mar 2006

Bexion Pharmaceuticals Alternatives & Competitors

View All Alternatives
Bexion Pharmaceuticals vs
CervoMed
CervoMed United States

Medicines for the Brain.

Post Ipo Debt
20 employees
Health Care, Pharmaceutical
Compare Bexion Pharmaceuticals vs CervoMed
Bexion Pharmaceuticals vs
Nereus Pharmaceuticals
Nereus Pharmaceuticals

Pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammati...

Series E
Biotechnology, Health Care
Compare Bexion Pharmaceuticals vs Nereus Pharmaceuticals
Bexion Pharmaceuticals vs
LYNK Pharmaceuticals
LYNK Pharmaceuticals

Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018.

Series C
11-50 employees
Biotechnology, Health Care
Compare Bexion Pharmaceuticals vs LYNK Pharmaceuticals
View all alternatives

FAQ About Bexion Pharmaceuticals

Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS.
Bexion Pharmaceuticals was founded in 2006.
Bexion Pharmaceuticals is headquartered in Covington, United States.
Bexion Pharmaceuticals operates in the following industries: Biopharma, Biotechnology, Life Sciences, Pharmaceutical.
Bexion Pharmaceuticals has approximately 27 employees.
Bexion Pharmaceuticals has completed 4 funding rounds, raising a total of $18.00M. The latest funding stage is Unknown.
Bexion Pharmaceuticals offers: Development of cancer therapies, Clinical-stage drug development, Phase 1b/2a clinical trials, Biologic therapy research.
Top alternatives and competitors to Bexion Pharmaceuticals include CervoMed, Nereus Pharmaceuticals, LYNK Pharmaceuticals, Scioto Biosciences, Inc, Elpiscience Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bexion Pharmaceuticals and CervoMed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bexion Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy